Impaired mRNA splicing and proteostasis in preadipocytes in obesity-related metabolic disease

Preadipocytes are crucial for healthy adipose tissue expansion. Preadipocyte differentiation is altered in obese individuals, which has been proposed to contribute to obesity-associated metabolic disturbances. Here, we aimed at identifying the pathogenic processes underlying impaired adipocyte diffe...

Full description

Bibliographic Details
Main Authors: Julia Sánchez-Ceinos, Rocío Guzmán-Ruiz, Oriol Alberto Rangel-Zúñiga, Jaime López-Alcalá, Elena Moreno-Caño, Mercedes Del Río-Moreno, Juan Luis Romero-Cabrera, Pablo Pérez-Martínez, Elsa Maymo-Masip, Joan Vendrell, Sonia Fernández-Veledo, José Manuel Fernández-Real, Jurga Laurencikiene, Mikael Rydén, Antonio Membrives, Raul M Luque, José López-Miranda, María M Malagón
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2021-09-01
Series:eLife
Subjects:
Online Access:https://elifesciences.org/articles/65996
_version_ 1828375501260980224
author Julia Sánchez-Ceinos
Rocío Guzmán-Ruiz
Oriol Alberto Rangel-Zúñiga
Jaime López-Alcalá
Elena Moreno-Caño
Mercedes Del Río-Moreno
Juan Luis Romero-Cabrera
Pablo Pérez-Martínez
Elsa Maymo-Masip
Joan Vendrell
Sonia Fernández-Veledo
José Manuel Fernández-Real
Jurga Laurencikiene
Mikael Rydén
Antonio Membrives
Raul M Luque
José López-Miranda
María M Malagón
author_facet Julia Sánchez-Ceinos
Rocío Guzmán-Ruiz
Oriol Alberto Rangel-Zúñiga
Jaime López-Alcalá
Elena Moreno-Caño
Mercedes Del Río-Moreno
Juan Luis Romero-Cabrera
Pablo Pérez-Martínez
Elsa Maymo-Masip
Joan Vendrell
Sonia Fernández-Veledo
José Manuel Fernández-Real
Jurga Laurencikiene
Mikael Rydén
Antonio Membrives
Raul M Luque
José López-Miranda
María M Malagón
author_sort Julia Sánchez-Ceinos
collection DOAJ
description Preadipocytes are crucial for healthy adipose tissue expansion. Preadipocyte differentiation is altered in obese individuals, which has been proposed to contribute to obesity-associated metabolic disturbances. Here, we aimed at identifying the pathogenic processes underlying impaired adipocyte differentiation in obese individuals with insulin resistance (IR)/type 2 diabetes (T2D). We report that down-regulation of a key member of the major spliceosome, PRFP8/PRP8, as observed in IR/T2D preadipocytes from subcutaneous (SC) fat, prevented adipogenesis by altering both the expression and splicing patterns of adipogenic transcription factors and lipid droplet-related proteins, while adipocyte differentiation was restored upon recovery of PRFP8/PRP8 normal levels. Adipocyte differentiation was also compromised under conditions of endoplasmic reticulum (ER)-associated protein degradation (ERAD) hyperactivation, as occurs in SC and omental (OM) preadipocytes in IR/T2D obesity. Thus, targeting mRNA splicing and ER proteostasis in preadipocytes could improve adipose tissue function and thus contribute to metabolic health in obese individuals.
first_indexed 2024-04-14T07:48:11Z
format Article
id doaj.art-af1e565ee14b40e49f3a99c51d6ad84c
institution Directory Open Access Journal
issn 2050-084X
language English
last_indexed 2024-04-14T07:48:11Z
publishDate 2021-09-01
publisher eLife Sciences Publications Ltd
record_format Article
series eLife
spelling doaj.art-af1e565ee14b40e49f3a99c51d6ad84c2022-12-22T02:05:17ZengeLife Sciences Publications LtdeLife2050-084X2021-09-011010.7554/eLife.65996Impaired mRNA splicing and proteostasis in preadipocytes in obesity-related metabolic diseaseJulia Sánchez-Ceinos0https://orcid.org/0000-0002-3131-7057Rocío Guzmán-Ruiz1Oriol Alberto Rangel-Zúñiga2Jaime López-Alcalá3Elena Moreno-Caño4Mercedes Del Río-Moreno5Juan Luis Romero-Cabrera6Pablo Pérez-Martínez7Elsa Maymo-Masip8Joan Vendrell9Sonia Fernández-Veledo10José Manuel Fernández-Real11Jurga Laurencikiene12Mikael Rydén13Antonio Membrives14Raul M Luque15José López-Miranda16María M Malagón17https://orcid.org/0000-0002-2419-2727Department of Cell Biology, Physiology and Immunology, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)/University of Córdoba/Reina Sofía University Hospital, Córdoba, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, SpainDepartment of Cell Biology, Physiology and Immunology, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)/University of Córdoba/Reina Sofía University Hospital, Córdoba, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, SpainCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain; Lipids and Atherosclerosis Unit, Department of Internal Medicine, IMIBIC, Córdoba, SpainDepartment of Cell Biology, Physiology and Immunology, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)/University of Córdoba/Reina Sofía University Hospital, Córdoba, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, SpainDepartment of Cell Biology, Physiology and Immunology, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)/University of Córdoba/Reina Sofía University Hospital, Córdoba, SpainCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain; OncObesity and Metabolism Group. Department of Cell Biology, Physiology and Immunology, IMIBIC/University of Córdoba/Reina Sofía University Hospital, Córdoba, SpainLipids and Atherosclerosis Unit, Department of Internal Medicine, IMIBIC, Córdoba, SpainLipids and Atherosclerosis Unit, Department of Internal Medicine, IMIBIC, Córdoba, SpainCIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERdem), Instituto de Salud Carlos III, Madrid, Spain; Hospital Universitari de Tarragona Joan XXIII, Institut d´Investigació Sanitària Pere Virgili Universitat Rovira i Virgil, Tarragona, SpainCIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERdem), Instituto de Salud Carlos III, Madrid, Spain; Hospital Universitari de Tarragona Joan XXIII, Institut d´Investigació Sanitària Pere Virgili Universitat Rovira i Virgil, Tarragona, SpainCIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERdem), Instituto de Salud Carlos III, Madrid, Spain; Hospital Universitari de Tarragona Joan XXIII, Institut d´Investigació Sanitària Pere Virgili Universitat Rovira i Virgil, Tarragona, SpainCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain; Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta University Hospital, and Eumetabolism and Health Group, Girona Biomedical Research Institute (IdibGi), Girona, SpainLipid Laboratory. Department of Medicine Huddinge/Karolinska Institute (KI)/Karolinska University Hospital, Stockholm, SwedenLipid Laboratory. Department of Medicine Huddinge/Karolinska Institute (KI)/Karolinska University Hospital, Stockholm, SwedenUnidad de Gestión Clínica de Cirugía General y Digestivo, Sección de Obesidad, Reina Sofia University Hospital, Córdoba, SpainCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain; OncObesity and Metabolism Group. Department of Cell Biology, Physiology and Immunology, IMIBIC/University of Córdoba/Reina Sofía University Hospital, Córdoba, SpainCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain; Lipids and Atherosclerosis Unit, Department of Internal Medicine, IMIBIC, Córdoba, SpainDepartment of Cell Biology, Physiology and Immunology, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)/University of Córdoba/Reina Sofía University Hospital, Córdoba, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, SpainPreadipocytes are crucial for healthy adipose tissue expansion. Preadipocyte differentiation is altered in obese individuals, which has been proposed to contribute to obesity-associated metabolic disturbances. Here, we aimed at identifying the pathogenic processes underlying impaired adipocyte differentiation in obese individuals with insulin resistance (IR)/type 2 diabetes (T2D). We report that down-regulation of a key member of the major spliceosome, PRFP8/PRP8, as observed in IR/T2D preadipocytes from subcutaneous (SC) fat, prevented adipogenesis by altering both the expression and splicing patterns of adipogenic transcription factors and lipid droplet-related proteins, while adipocyte differentiation was restored upon recovery of PRFP8/PRP8 normal levels. Adipocyte differentiation was also compromised under conditions of endoplasmic reticulum (ER)-associated protein degradation (ERAD) hyperactivation, as occurs in SC and omental (OM) preadipocytes in IR/T2D obesity. Thus, targeting mRNA splicing and ER proteostasis in preadipocytes could improve adipose tissue function and thus contribute to metabolic health in obese individuals.https://elifesciences.org/articles/65996preadipocytesobesity-related metabolic diseasesRNA splicingER-proteostasisUPRERAD
spellingShingle Julia Sánchez-Ceinos
Rocío Guzmán-Ruiz
Oriol Alberto Rangel-Zúñiga
Jaime López-Alcalá
Elena Moreno-Caño
Mercedes Del Río-Moreno
Juan Luis Romero-Cabrera
Pablo Pérez-Martínez
Elsa Maymo-Masip
Joan Vendrell
Sonia Fernández-Veledo
José Manuel Fernández-Real
Jurga Laurencikiene
Mikael Rydén
Antonio Membrives
Raul M Luque
José López-Miranda
María M Malagón
Impaired mRNA splicing and proteostasis in preadipocytes in obesity-related metabolic disease
eLife
preadipocytes
obesity-related metabolic diseases
RNA splicing
ER-proteostasis
UPR
ERAD
title Impaired mRNA splicing and proteostasis in preadipocytes in obesity-related metabolic disease
title_full Impaired mRNA splicing and proteostasis in preadipocytes in obesity-related metabolic disease
title_fullStr Impaired mRNA splicing and proteostasis in preadipocytes in obesity-related metabolic disease
title_full_unstemmed Impaired mRNA splicing and proteostasis in preadipocytes in obesity-related metabolic disease
title_short Impaired mRNA splicing and proteostasis in preadipocytes in obesity-related metabolic disease
title_sort impaired mrna splicing and proteostasis in preadipocytes in obesity related metabolic disease
topic preadipocytes
obesity-related metabolic diseases
RNA splicing
ER-proteostasis
UPR
ERAD
url https://elifesciences.org/articles/65996
work_keys_str_mv AT juliasanchezceinos impairedmrnasplicingandproteostasisinpreadipocytesinobesityrelatedmetabolicdisease
AT rocioguzmanruiz impairedmrnasplicingandproteostasisinpreadipocytesinobesityrelatedmetabolicdisease
AT oriolalbertorangelzuniga impairedmrnasplicingandproteostasisinpreadipocytesinobesityrelatedmetabolicdisease
AT jaimelopezalcala impairedmrnasplicingandproteostasisinpreadipocytesinobesityrelatedmetabolicdisease
AT elenamorenocano impairedmrnasplicingandproteostasisinpreadipocytesinobesityrelatedmetabolicdisease
AT mercedesdelriomoreno impairedmrnasplicingandproteostasisinpreadipocytesinobesityrelatedmetabolicdisease
AT juanluisromerocabrera impairedmrnasplicingandproteostasisinpreadipocytesinobesityrelatedmetabolicdisease
AT pabloperezmartinez impairedmrnasplicingandproteostasisinpreadipocytesinobesityrelatedmetabolicdisease
AT elsamaymomasip impairedmrnasplicingandproteostasisinpreadipocytesinobesityrelatedmetabolicdisease
AT joanvendrell impairedmrnasplicingandproteostasisinpreadipocytesinobesityrelatedmetabolicdisease
AT soniafernandezveledo impairedmrnasplicingandproteostasisinpreadipocytesinobesityrelatedmetabolicdisease
AT josemanuelfernandezreal impairedmrnasplicingandproteostasisinpreadipocytesinobesityrelatedmetabolicdisease
AT jurgalaurencikiene impairedmrnasplicingandproteostasisinpreadipocytesinobesityrelatedmetabolicdisease
AT mikaelryden impairedmrnasplicingandproteostasisinpreadipocytesinobesityrelatedmetabolicdisease
AT antoniomembrives impairedmrnasplicingandproteostasisinpreadipocytesinobesityrelatedmetabolicdisease
AT raulmluque impairedmrnasplicingandproteostasisinpreadipocytesinobesityrelatedmetabolicdisease
AT joselopezmiranda impairedmrnasplicingandproteostasisinpreadipocytesinobesityrelatedmetabolicdisease
AT mariammalagon impairedmrnasplicingandproteostasisinpreadipocytesinobesityrelatedmetabolicdisease